Teva Pharmaceutical Industries Limited (LON:0LER)

LON:0LER Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 9, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	27,929	19,974	9,188	8,407	6,525	7,746
Market Cap Growth	37.65%	117.40%	9.29%	28.84%	-15.77%	-4.14%
Enterprise Value	38,986	32,974	23,815	25,127	23,592	26,251
Last Close Price	24.13	17.55	8.19	7.50	5.86	6.94
PE Ratio	52.65	-	-	-	21.19	-
PS Ratio	2.24	1.51	0.74	0.68	0.56	0.64
PB Ratio	5.18	4.37	1.44	1.18	0.79	0.96
P/FCF Ratio	64.95	33.39	13.90	9.72	37.44	16.58
P/OCF Ratio	35.22	20.05	8.56	6.37	11.07	8.70
EV/Sales Ratio	3.13	2.50	1.91	2.03	2.01	2.15
EV/EBITDA Ratio	11.08	9.32	7.00	7.63	7.25	7.77
EV/EBIT Ratio	14.64	12.24	9.54	11.37	10.38	11.73
EV/FCF Ratio	90.66	55.12	36.03	29.06	135.36	56.18
Debt / Equity Ratio	2.36	3.18	2.50	2.52	2.10	2.40
Debt / EBITDA Ratio	3.61	3.98	4.53	5.26	5.19	5.57
Debt / FCF Ratio	29.57	24.28	24.08	20.80	99.97	41.59
Asset Turnover	0.41	0.40	0.36	0.33	0.32	0.31
Inventory Turnover	2.30	2.41	2.09	2.08	2.02	2.02
Quick Ratio	0.52	0.50	0.54	0.57	0.61	0.51
Current Ratio	1.11	0.98	1.02	1.05	1.14	0.99
Return on Equity (ROE)	9.71%	-28.30%	-7.36%	-25.19%	4.09%	-31.38%
Return on Assets (ROA)	5.49%	5.09%	4.54%	3.63%	3.91%	3.53%
Return on Capital (ROIC)	8.95%	8.06%	6.78%	5.11%	5.31%	4.77%
Return on Capital Employed (ROCE)	12.60%	12.70%	10.20%	8.20%	8.40%	8.20%
Earnings Yield	1.90%	-6.55%	-4.78%	-24.15%	4.72%	-37.73%
FCF Yield	1.54%	3.00%	7.20%	10.29%	2.67%	6.03%
Buyback Yield / Dilution	-2.33%	-1.07%	-0.81%	-0.27%	-1.10%	-0.37%
Total Shareholder Return	-2.33%	-1.07%	-0.81%	-0.27%	-1.10%	-0.37%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.